Boston, MA -- (SBWIRE) -- 05/15/2012 -- GlobalData, the industry analysis specialist, has released its new report, "Urinary Tract Infections (UTI) Therapeutics - Pipeline Assessment and Market Forecasts to 2018". The report is an essential source of information and analysis on the global Urinary Tract Infections Therapeutics market. The report identifies the key trends shaping and driving the global Urinary Tract Infections Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Urinary Tract Infections Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

View Full Report Details and Table of Contents

The report provides information on the key drivers and challenges of the Urinary Tract Infections Therapeutics market. Its scope includes -

- Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Urinary Tract Infections Therapeutics market revenues data from 2005 to 2010, forecast for eight years to 2018.
- Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes.
- Analysis of the current and future competition in the seven key countries Urinary Tract Infections Therapeutics market.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
- Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Urinary Tract Infections Therapeutics market.
- Analysis of key recent licensing and partnership agreements in Urinary Tract Infections Therapeutics market

Reasons to Get this Report

The report will enhance your decision making capability. It will allow you to -

- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global Urinary Tract Infections Therapeutics market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Urinary Tract Infections Therapeutics market in future.

Companies Mentioned in this Report: AstraZeneca PLC, Cubist Pharmaceuticals, Forest Laboratories

About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

- Urinary Tract Infections (UTI) - Pipeline Assessment and Market Forecasts to 2017
- Anti-Bacterials Market to 2016 - Cephalosporins, Penicillins, Macrolides and Fluoroquinolones to Drive the Anti-Bacterials Market
- Urinary Incontinence (UI) Therapeutics - Pipeline Assessment and Market Forecasts to 2018
- Urinary Tract Infections - Pipeline Review, H1 2012
- Urinary Tract Infections - Pipeline Review, Q4 2010
- Urinary Tract Infections - Pipeline Review, H2 2011
- Urological Disorders Therapeutics to 2017 - Large Number of Licensing Deals for Approved Products Reflects a Pessimistic R&D Future
- Staphylococcal Infections Therapeutics - Pipeline Assessment and Market Forecasts to 2017
- Erectile Dysfunction Therapeutics - Pipeline Assessment and Market Forecasts to 2018
- Candidiasis Therapeutics - Pipeline Assessment and Market Forecasts to 2018